Variations between the anatomical and functional distribution, based on 99m technetium -mebrofinate SPECT-CT scan, in patients at risk of post hepatectomy liver failure

HPB (Oxford). 2021 Dec;23(12):1807-1814. doi: 10.1016/j.hpb.2021.04.014. Epub 2021 Apr 27.

Abstract

Background: The aim of the current study is to investigate the variations of anatomical (LVRem%) and functional remnant volumes (fLVRem%) and the dynamic uptake of Technetium-Mebrofinate (FRLF) measured from 99m Technetium-Mebrofinate SPECT-CT scan (TMSCT) in patients at high risk of post-hepatectomy liver failure (PHLF).

Methods: Variations in the measures of LVRem% and fLVRem% were assessed. The predictive accuracies of LVRem%, fLVRem% and FRLF with respect to PHLF were reported.

Results: From the N = 92 scans performed, LVRem% and fLVRem% returned identical results in 15% of cases, and ±10 percentage points in 79% of cases. Some patients had larger discrepancies, with difference of >10 percentage points in 21% of cases. The difference was significant in those with primary liver cancers (-4.4 ± 9.2, p = 0.002). For the N = 29 patients that underwent surgery as planned on TMSCT, FRLF was a strong predictor of PHLF, with an AUROC of 0.83 (p = 0.005).

Conclusion: TMSCT is emerging as a useful modality in pre-operative assessment of patients undergoing major liver resection. For those with primary liver cancer, there is a significant variation in the anatomical and functional distributions that needs considered in surgical planning. Reduced FRLF, measured as the dynamic uptake in the future liver remnant, is a strong predictor of PHLF.

MeSH terms

  • Hepatectomy / adverse effects
  • Humans
  • Liver Failure* / diagnostic imaging
  • Liver Failure* / etiology
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / surgery
  • Postoperative Complications
  • Retrospective Studies
  • Single Photon Emission Computed Tomography Computed Tomography
  • Technetium

Substances

  • Technetium